The incidence of childhood cancer increased through the second half of the twentieth century and continues to increase today.
Incredible progress has been made in treating childhood cancers but the pace of progress has now slowed and a substantial minority of patients are failed by therapy and do not survive.
In addition, the tremendous gains in survival have been achieved through the use of increasingly intensive treatment regimens, putting young patients at risk of adverse, treatment-related effects.
- We want to understand more about why children develop cancer, to find explanations for the increase in risk and to establish whether prevention is a possibility.
- We want to drive forward the development of novel approaches to diagnosis, identification of markers of likely outcome and improved treatments for childhood cancer in order to tackle those forms which still elude successful treatment and to minimise the risk of adverse, treatment-related effects.
- We want to understand more about the long-term risks faced by childhood cancer survivors, of whom there are now more than 30,000 in the UK.
Read more: Our full research strategy